Form 8-K - Current report:
SEC Accession No. 0001104659-21-136957
Filing Date
2021-11-10
Accepted
2021-11-10 16:21:18
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132498d1_8k.htm   iXBRL 8-K 27273
2 EXHIBIT 99.1 tm2132498d1_ex99-1.htm EX-99.1 111795
6 GRAPHIC image_001.jpg GRAPHIC 4534
  Complete submission text file 0001104659-21-136957.txt   335443

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eyen-20211110.xsd EX-101.SCH 3198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20211110_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20211110_pre.xml EX-101.PRE 22719
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132498d1_8k_htm.xml XML 3706
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 211396980
SIC: 2834 Pharmaceutical Preparations